ADC Therapeutics SA (ADCT)
4.57
-0.33
(-6.73%)
USD |
NYSE |
May 06, 12:20
ADC Therapeutics Free Cash Flow: -121.90M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -121.90M |
| September 30, 2023 | -140.62M |
| June 30, 2023 | -104.00M |
| March 31, 2023 | -119.78M |
| December 31, 2022 | -139.00M |
| September 30, 2022 | -149.04M |
| June 30, 2022 | -211.91M |
| Date | Value |
|---|---|
| March 31, 2022 | -218.95M |
| December 31, 2021 | -239.75M |
| September 30, 2021 | -230.06M |
| June 30, 2021 | -214.82M |
| March 31, 2021 | -194.77M |
| December 31, 2020 | -171.54M |
Free Cash Flow Range, Past 5 Years
-239.75M
Minimum
Dec 2021
-104.00M
Maximum
Jun 2023
-173.55M
Average
-171.54M
Median
Dec 2020
Free Cash Flow Benchmarks
| Roche Holding AG | 12.82B |
| Novartis AG | 10.25B |
| AC Immune SA | -68.17M |
| CRISPR Therapeutics AG | -272.34M |
| Addex Therapeutics Ltd | -8.908M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -33.07M |
| Cash from Investing (Quarterly) | -0.527M |
| Cash from Financing (Quarterly) | 1.639M |
| Free Cash Flow Per Share (Quarterly) | -0.4058 |
| Free Cash Flow to Equity (Quarterly) | -34.09M |
| Free Cash Flow to Firm (Quarterly) | -23.09M |
| Free Cash Flow Yield | -32.65% |